Responses
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx
Compose a Response to This Article
Other responses
No responses have been published for this article.